Deutsche Bank Remains Optimistic on Mead Johnson (MJN) After Q4 Print, Boosts PT

Article Related Press Releases (1) Related Articles (2) Stock Quotes (1) Comments (0)

Deutsche Bank raised its price target on Mead Johnson Nutrition (NYSE: MJN) from $77 to $81 and affirmed its Buy rating following Q4 results.

The firm comments, "In the face of building pessimism in late 2012 and into 2013, we maintained an optimistic view on Mead. With broad share gains in a typically rational and highly profitable category, the LT outlook remains bright. With an eventual U.S. recovery, non-China EM markets ramping up and good prospects in China/HK along with a reasonable global CPG valuation, we retain our BUY."

For an analyst ratings summary and ratings history on Mead Johnson Nutrition click here. For more ratings news on Mead Johnson Nutrition click here.

Shares of Mead Johnson Nutrition closed at $76.00 yesterday, with a 52 week range of $61.27-$88.72.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: Wedbush Downgrades XenoPort (XNPT) to Neutral
• Morgan Stanley Says Tesla (TSLA) 'Top Pick in U.S. Autos'
• Biogen's (BIIB) BG-12 Data Not Inflated

Create E-mail Alert Related Categories

Analyst Comments, Analyst EPS View, Analyst PT Change

Related Entities

Deutsche Bank

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?